Position in XERS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,625,049
+$3,265,880 QoQ
Shares Held
1,594,072
-1.2% QoQ
Ownership
0.874%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 238 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $1,964,785,401 across 53 Drug Manufacturers - Specialty & Generic names. XERS ranks #26 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,199,799 | $229,937,554 | |
| 2 | VTRS |
Viatris Inc
|
13,564,872 | $215,410,166 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,129,240 | $207,658,650 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
5,173,865 | $179,377,897 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
631,892 | $106,499,075 | |
| 6 | ALKS |
Alkermes plc.
|
2,023,984 | $106,056,760 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
814,096 | $90,315,809 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
165,979 | $89,932,399 |
All Filings in XERS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,625,049 | 1,594,072 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $9,359,169 | 1,613,650 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $12,312,103 | 1,568,421 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $14,615,003 | 1,795,455 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $10,607,839 | 2,271,486 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $15,317,175 | 2,790,014 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $5,392,062 | 1,590,579 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $2,383,859 | 836,442 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $710,244 | 315,664 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $555,699 | 251,448 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $607,918 | 258,689 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $247,082 | 132,840 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $587,251 | 224,142 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $203,023 | 124,555 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $217,906 | 163,840 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $191,327 | 122,646 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $173,311 | 112,540 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $1,856,652 | 725,255 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $667,133 | 227,691 | Shares | Defined | 2022-02-17 | |
| No filing history on record for this holder in this stock. | ||||||